TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer - Ntavatzikos, A.; Spathis, A.; Patapis, P.; Machairas, N.; Vourli, G.; Peros, G.; Papadopoulos, I.; Panayiotides, I.; Koumarianou, A. (World Journal of Gastrointestinal Oncology, 2019)